Epigenetics and Cancer Prevention
The Epigenetics and Cancer Prevention group focuses on understanding the pathogenesis of colorectal cancer, and develop strategies for its primary and secondary prevention. One of the primary focuses of the research program is cancer prevention through development of robust molecular biomarkers that can facilitate early diagnosis, better prognosis or predict response to chemotherapies for human cancer, particularly colorectal cancer.
The Mucosal Pathobiology group focuses on assessing the intestinal mucosa during normal conditions and disease pathogenesis. This includes intestinal epithelial cell homeostasis and barrier function during inflammatory conditions and progression to cancer.